Is Antares Pharma Inc (ATRS) Stock at the Top of the Medical Instruments & Supplies Industry?

Thursday, November 04, 2021 11:58 AM | InvestorsObserver Analysts

Mentioned in this article

Is Antares Pharma Inc (ATRS) Stock at the Top of the Medical Instruments & Supplies Industry?

Antares Pharma Inc (ATRS) is near the top in its industry group according to InvestorsObserver. ATRS gets an overall rating of 54. That means it scores higher than 54 percent of stocks. Antares Pharma Inc gets a 75 rank in the Medical Instruments & Supplies industry. Medical Instruments & Supplies is number 69 out of 148 industries.

ATRS has an Overall Score of 54. Find out what this means to you and get the rest of the rankings on ATRS!

See Full ATRS Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 54 would rank higher than 54 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes

InvestorsObserver

’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Antares Pharma Inc Stock Today?

Antares Pharma Inc (ATRS) stock is lower by -6.25% while the S&P 500 is higher by 0.17% as of 11:57 AM on Thursday, Nov 4. ATRS is down -$0.25 from the previous closing price of $3.92 on volume of 599,771 shares. Over the past year the S&P 500 is higher by 35.57% while ATRS is higher by 22.26%. ATRS earned $0.38 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 9.77. Click Here to get the full Stock Report for Antares Pharma Inc stock.